CoinScoopUS Treasury drafts rules to maintain pharmaceutical licensing deals with China
The US Treasury Department is drafting rules intended to keep most pharmaceutical licensing agreements with China intact, seeking to balance economic interests with national security in the biotech industry.
Summaries are written by AI from the original article. Not investment advice.